Potential FDA Peptide Reclassification 2026 What It Means for Patients Beverly Hills Rejuvenation Center FDA July 2026 Peptide Meeting: What Patients Need to Know About Access, Approval, and Safety Meto blog In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few 2023 FDA approvals: unprecedented volume at moderate value